Uncategorized

FDA lifts MacroGenics hold; Oxford and Bristol Myers team up

FDA lifts MacroGenics hold; Oxford and Bristol Myers team up

Published

on

Plus, news about Boston Oncology, Garda and Assertio, an Everest deal and Forte’s raise:

🟢 FDA ends partial hold on MacroGenics cancer drug: In February, the agency stopped a Phase 2 trial of lorigerlimab after …​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version